Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer
Clinical trial NCT03272217 · TERMINATED
Trial details
- NCT number
- NCT03272217
- Sponsor
- Arjun Balar, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-13
- Primary completion
- 2021-05-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.